Inventor · disambiguated record
Lihui Xu
Also filed as: XU LIHUI
5 granted patents·10 pending applications·26 citations·filing 2010–2024
75Inventor score
Files withPALLEON PHARMACEUTICALS INC8MERRIMACK PHARMACEUTICALS INC4BAUM JASON1SCHOEBERL BIRGIT1UNIV OHIO STATE1
Top patents by PatentIndex Score
15 records- 0191US8476409B2Bispecific anti-IGF-1R and anti-ErbB3 antibodiesBAUM JASON·Filed 2012·Granted Jul 2, 2013·22 cites·15 claims
- 0279US9556274B2Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2013·Granted Jan 31, 2017·2 cites·10 claims
- 0373US9527914B2Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Dec 27, 2016·1 cites·6 claims
- 0469US11965188B2Recombinant human sialidases, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2019·Granted Apr 23, 2024·1 cites·43 claims
- 0562US2024344046A1Recombinant human sialidases, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0661US9938346B2Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Granted Apr 10, 2018·0 cites·24 claims
- 0754US2017210809A1Bispecific binding agents targeting the igf-1r and erbb3 pathways and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0850US2012244163A1Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereofSCHOEBERL BIRGIT·Filed 2012·Application pending·0 cites
- 0948US2024067729A1Anti-pd-l1 antibodies and fusion proteins thereofPALLEON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1048US2024059773A1Sialidase-pd-1-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1142US2022372458A1Sialidase-pd-l1-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1242US2022362351A1Recombinant sialidases and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1340US2022356457A1Recombinant human sialidases, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1439US2021395333A1Multimeric proteins for detecting a carbohydrate and/or treating a siglec-mediated disorderPALLEON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1533US2010227776A1Rapid Genotyping of SNPsUNIV OHIO STATE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lihui Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →